Advaxis Inc. [NASDAQ: ADXS] stock went on a downward path that fall over -27.27% on Tuesday, amounting to a one-week price decrease of less than -27.79%. The company report on November 24, 2020 that Advaxis, Inc. Announces Pricing of $8 Million Public Offering.
Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, announced the pricing of an underwritten public offering of (i) 26,666,666 shares of common stock and warrants to purchase up to 13,333,333 shares of common stock. The shares of common stock and warrants are being sold together at a combined public offering price of $0.30 per share. The warrants will have an exercise price of $0.35 per share, will be immediately exercisable and will expire five years from the date of issuance. The Company has granted the underwriters a 30-day option to purchase up to an additional 3,999,999 shares of common stock and/or 1,999,999 warrants to cover over-allotments, if any.
The Company plans to use the net proceeds from the offering to fund its continued research and development initiatives in connection with expanding its product pipeline including, but not limited to, investment in its ADXS-HOT program and for general corporate purposes. The Company may also use a portion of the net proceeds to acquire or invest in other businesses, products and technologies.
Over the last 12 months, ADXS stock dropped by -34.26%. The average equity rating for ADXS stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $18.96 million, with 61.63 million shares outstanding and 56.55 million shares in the current float. Compared to the average trading volume of 2.03M shares, ADXS stock reached a trading volume of 44641448 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Advaxis Inc. [ADXS]:
Barclays have made an estimate for Advaxis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 03, 2016. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on September 22, 2015, representing the official price target for Advaxis Inc. stock. Previously, the target price had yet another raise to $30, while Guggenheim analysts kept a Buy rating on ADXS stock. On June 16, 2015, analysts increased their price target for ADXS shares from 25 to 30.
The Average True Range (ATR) for Advaxis Inc. is set at 0.04, with the Price to Sales ratio for ADXS stock in the period of the last 12 months amounting to 63.19. The Price to Book ratio for the last quarter was 0.56, with the Price to Cash per share for the same quarter was set at 0.36.
ADXS Stock Performance Analysis:
Advaxis Inc. [ADXS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -27.79. With this latest performance, ADXS shares dropped by -34.20% in over the last four-week period, additionally sinking by -59.03% over the last 6 months – not to mention a drop of -34.26% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADXS stock in for the last two-week period is set at 30.43, with the RSI for the last a single of trading hit 22.61, and the three-weeks RSI is set at 34.00 for Advaxis Inc. [ADXS]. The present Moving Average for the last 50 days of trading for this stock 0.4006, while it was recorded at 0.3657 for the last single week of trading, and 0.5787 for the last 200 days.
Insight into Advaxis Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Advaxis Inc. [ADXS] shares currently have an operating margin of -75.02. Advaxis Inc.’s Net Margin is presently recorded at -79.54.
Return on Total Capital for ADXS is now -49.28, given the latest momentum, and Return on Invested Capital for the company is -52.25. Return on Equity for this stock declined to -52.25, with Return on Assets sitting at -30.90.
Reflecting on the efficiency of the workforce at the company, Advaxis Inc. [ADXS] managed to generate an average of -$474,629 per employee.Advaxis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.40 and a Current Ratio set at 8.40.
ADXS Stock EPS
With the latest financial reports released by the company, Advaxis Inc. posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.31/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 51.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADXS.
Advaxis Inc. [ADXS] Insider Position Details
There are presently around $2 million, or 25.30% of ADXS stock, in the hands of institutional investors. The top three institutional holders of ADXS stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 3,266,143, which is approximately -6.653% of the company’s market cap and around 0.12% of the total institutional ownership; BLACKROCK INC., holding 870,007 shares of the stock with an approximate value of $0.25 million in ADXS stocks shares; and VANGUARD GROUP INC, currently with $0.23 million in ADXS stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Advaxis Inc. stocks held by institutional investors increased at the end of December and at the time of the December reporting period, where 10 institutional holders increased their position in Advaxis Inc. [NASDAQ:ADXS] by around 575,755 shares. Additionally, 14 investors decreased positions by around 443,495 shares, while 15 investors held positions by with 6,100,045 shares. The mentioned changes placed institutional holdings at 7,119,295 shares, according to the latest SEC report filing. ADXS stock had 4 new institutional investments in for a total of 399,491 shares, while 8 institutional investors sold positions of 162,779 shares during the same period.